ALTAY THERAPEUTICS
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It was founded in 2019 and is headquartered in San Francisco, California.
ALTAY THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2019-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.altaytherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
3.24 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Content Delivery Network Wix Wix Media
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Board_member
2022-09-01
Current Employees Featured
Ali Ozes Founder and CEO @ Altay Therapeutics
Founder and CEO
2019-03-01
Osman Nidai Ozes Founder and Chief Scientific Officer @ Altay Therapeutics
Founder and Chief Scientific Officer
2019-03-01
Founder
Investors List
Solve FSHD
Solve FSHD investment in Seed Round - Altay Therapeutics
Tachyon Ventures
Tachyon Ventures investment in Seed Round - Altay Therapeutics
FSHD Global
FSHD Global investment in Seed Round - Altay Therapeutics
Friends of FSH Research
Friends of FSH Research investment in Grant - Altay Therapeutics
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Altay Therapeutics
Erik Peterson
Erik Peterson investment in Seed Round - Altay Therapeutics
Y Combinator
Y Combinator investment in Seed Round - Altay Therapeutics
Bossanova Investimentos
Bossanova Investimentos investment in Seed Round - Altay Therapeutics
Official Site Inspections
http://www.altaytherapeutics.com Semrush global rank: 9.11 M Semrush visits lastest month: 445
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
Altaytherapeutics.com lookup results from whois.tucows.com server:
- Domain created: 8th-Apr-2019
- Domain updated: 3rd-Apr-2024
- Domain expires: 8th-Apr-2025 0 Years, 86 Days left
- Website age: 5 Years, 279 Days
- Registrar Domain ID: 2377941674_DOMAIN_COM-VRSN
- Registrar Url: http://www.tucows.com
- Registrar WHOIS Server: whois.tucows.com
- Registrar Abuse Contact Email: domainabuse@tucows.com
- Registrar Abuse Contact Phone: +1.4165350123
- Name server:
- NS14.WIXDNS.NET
- NS15.WIXDNS.NET
More informations about "Altay Therapeutics"
About Us - Altay Tx
Our location Altay Therapeutics is located in MBC Biolabs in San Carlos in the heart of the scientific and entrepreneurial hub. We are near world-class research organizations such as the Gladstone Institute, Stanford University, University …See details»
Altay Therapeutics - Crunchbase Company Profile & Funding
Contact Email info@altaytherapeutics.com Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is …See details»
Altay Therapeutics Company Profile | Management and ... - Datanyze
Www.altaytherapeutics.com . Altay Therapeutics Profile and History. Altay develops novel small molecules that inhibit transcription factors that are validated drivers of disease. Our platform, …See details»
ALTAY THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALTAY THERAPEUTICS, INC. of San Carlos, CA. Get the latest business insights from Dun & …See details»
Altay Therapeutics - Y Combinator
Altay develops disease-modifying therapies targeting transcription…. Founded in 2019 by Ali Ozes and Osman Ozes, Altay Therapeutics has 6 employees based in San Carlos, CA, USA.See details»
Altay Therapeutics - Overview, News & Similar companies
Sep 21, 2022 View Altay Therapeutics (www.altaytherapeutics.com) location in California, United States , revenue, industry and description. ... VANCOUVER, British Columbia, Sept. …See details»
Altay Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Altay Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Neoplasms, Technology Platform:Biological …See details»
Altay Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Altay Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Altay Therapeutics - LinkedIn
Altay Therapeutics | 1,292 followers on LinkedIn. We develop small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers | Using our unique platform ...See details»
Altay Therapeutics - PitchBook
Altay Therapeutics General Information Description. Developer of disease-modifying therapies intended to treat neuromuscular diseases and oncology. The company's method targets …See details»
Altay Therapeutics - VentureRadar
Similar Companies: Pliant Therapeutics USA Publicly Traded Pliant Therapeutics is a biotechnology company unraveling and targeting the key biological pathways driving fibrosis. …See details»
Altay Therapeutics - VentureRadar
Website: https://www.altaytherapeutics.com/ Founded in 2019, Altay Therapeutics develops novel small molecules that inhibit transcription factors that are validated ...See details»
Altay Therapeutics - Company Profile - Tracxn
Altay Therapeutics - Developer of therapeutics for chronic liver diseases and cancer. Raised a total funding of $6.71M over 3 rounds from 4 investors. Founded by Ali Rayet Ozes and …See details»
Our Technology | Altay Tx
Diseases are caused by multifactorial changes in the cell. Transcription factors (TFs) are a class of proteins that regulate dozens or even hundreds of genes.See details»
SOLVE FSHD invests US$3 million in Altay Therapeutics
SOLVE FSHD invests US$3 million in Altay Therapeutics VANCOUVER, B.C., Sept 21, 2022 – SOLVE FSHD, a venture-philanthropy organization catalyzing the…See details»
SOLVE FSHD invests US$3 million in Altay Therapeutics
Sep 21, 2022 He has committed $100 million of his own money to create SOLVE FSHD and kick-start funding into projects that fit the organization’s mission to accelerate research into …See details»
News - Altay Tx
SOLVE FSHD Invests $3M in Altay Therapeutics to develop novel inhibitors for FSHD September 2022 We're are very excited to be working on first-in-class inhibitors for FSHD using our …See details»
SOLVE FSHD invests US$3 million in Altay Therapeutics - Yahoo …
VANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- SOLVE FSHD, a venture-philanthropy organization catalyzing the pace of innovation to accelerate a cure for …See details»
R&D Pipeline - Altay Tx
Facioscapulohumeral muscular dystrophy (FSHD) Fibrosis & Inflammatory diseases. Ewing's Sarcoma & Prostate CancerSee details»